Accelerate Program for Quebec Emerging Companies

The eligibility criteria for the grant include the following factors: 1. Differentiation and competitive advantage of the technology 2. Market opportunity 3. Quality of the team 4. Scope and strength of intellectual property (IP) coverage 5. Potential return on investment 6. Impact of the adMare seed investment in building the company to a value inflection point that makes it attractive to private capital adMare's strategic investment focus includes biopharmaceuticals, medical devices, and digital health solutions.

- Differentiation and competitive advantage of the technology - Market opportunity - Quality of the team - Scope and strength of IP coverage - Potential return on investment

To apply for the grant from adMare, you can follow these steps: 1. Visit the adMare website and navigate to the grant application section. 2. Review the eligibility criteria and requirements for the grant. 3. Prepare your application materials, including a proposal outlining your project, team information, and any other requested documents. 4. Submit your application through the specified online portal or email address. 5. Keep track of any communication from adMare regarding the status of your application.

- adMare builds companies by partnering with and investing in technology innovators and entrepreneurs, particularly academic researchers and emerging Canadian life sciences companies. - They have helped build 29 portfolio companies that have attracted over $2.3B of risk capital, employing close to 1,000 Canadians with a combined value of $4B. - adMare translates leading academic research into new companies by proactively identifying innovative research and early technologies that can be collaboratively translated into new therapeutic products and other health innovations. - They focus on novel and transformative pre-clinical technologies and platforms addressing unmet medical needs to add significant value. - The adMare investment criteria include differentiation and competitive advantage of technology, market opportunity, quality of the team, IP coverage, potential return on investment, and impact of their seed investment. - They strategically invest in biopharmaceuticals, medical devices, and digital health solutions. - adMare provides seed capital, scientific and business expertise, infrastructure, and network to help build or grow dream companies. - They collaborate with existing Canadian life sciences companies in a shared risk/reward model to enable further product pipeline development and business advancement.